Youcare Pharmaceutical Group Co. Ltd. Class A 688658

SSE · China · Health Technology

CNY 14.04+1.07 (+8.25%)

Market closed· Sep 30, 2026, 7:00 AM UTC· CNY · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

Youcare Pharmaceutical Group Co. Ltd. Class A 688658

SSE · China · Health Technology

CNY 14.04+1.07 (+8.25%)

Market closed· Sep 30, 2026, 7:00 AM UTC· CNY · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

-18.42% · 6MFull-screen chart

Open CNY 13.00High CNY 14.49Low CNY 12.88Close CNY 14.04Volume 24.13M

Sep 30, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: CNY 12.97
Day range: CNY 12.88 – CNY 14.49
52-week range: CNY 11.29 – CNY 32.12
Volume: 24.13M
Market cap: CNY 6.32B
Next earnings date: 2026-10-29
Avg. volume (1Y): 11.70M

Performance

1 week

+1.74%

1 month

+4.78%

3 months

-0.28%

6 months

-27.22%

Year to date

-43.61%

1 year

-36.61%

Total return, dividends included.

Company profile

Sector: Health Technology
Industry: Pharmaceuticals: Major
Country: China
Exchange: SSE
Shares outstanding: 444.48M
Employees: 2,870
ISIN: CNE100005XQ2
Beta: 0.98

Technical view

Mixed

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

News

Yahoo FinanceFeb 28, 2026

Fangzhou and Youcare Pharmaceutical Group Form Strategic Alliance to Advance AI-Driven Chronic Care Services

BEIJING, Feb. 28, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI-driven Internet healthcare solutions, has signed a strategic collaboration agreement with Youcare Pharmaceutical Group (悦康药业集团 or “Youcare”) (SH: 688658), a leading integrated pharmaceutical enterprise in China. The partnership aims to accelerate the digital transformation and enhancement of chronic disease services through the application of artificial intelligence (“AI

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.